Publikace
- Clinical Candidates Targeting the ATR-CHK1-WEE1 Axis in Cancer2021 | Publikace bez příslušnosti k fakultě
- In silico library screening to find novel anticancer agent with chemosensitizing properties: focus on targeting ataxia telangiectasia and Rad3 related kinase2024 | Lékařská fakulta v Hradci Králové
- 2,6-Disubstituted 7-(naphthalen-2-ylmethyl)-7H-purines as a new class of potent antitubercular agents inhibiting DprE12023 | Farmaceutická fakulta v Hradci Králové
- 7-Azaindole, 2,7-diazaindole, and 1H-pyrazole as core structures for novel anticancer agents with potential chemosensitizing properties2022 | Farmaceutická fakulta v Hradci Králové, Lékařská fakulta v Hradci Králové
- Discovery of ATR kinase inhibitor berzosertib (VX-970, M6620): Clinical candidate for cancer therapy2020 | Lékařská fakulta v Hradci Králové
- Fork Cleavage-Religation Cycle and Active Transcription Mediate Replication Restart after Fork Stalling at Co-transcriptional R-Loops2020 | Ústřední knihovna
- Novel quinazolin-4-one derivatives as potentiating agents of doxorubicin cytotoxicity2019 | Lékařská fakulta v Hradci Králové
- Purin-6-one and pyrrolo[2,3-d]pyrimidin-4-one derivatives as potentiating agents of doxorubicin cytotoxicity2018 | Lékařská fakulta v Hradci Králové
- Novel caffeine derivatives with antiproliferative activity2016 | Lékařská fakulta v Hradci Králové
- Small Molecules Targeting Ataxia Telangiectasia and Rad3-Related (ATR) Kinase: An Emerging way to Enhance Existing Cancer Therapy2016 | Publikace bez příslušnosti k fakultě
Loading network view...